Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Wrong product administered
Clinical narrative: Wrong vaccine administered; Felt very tired the next day; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID. The reporter is the patient.  A 90-year-old female patient received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient didn't receive BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5). The patient's relevant medical history included: "Arthritic knees" (unspecified if ongoing), notes: has arthritic knees not she does not have good bones.; "has arthritic knees not she does not have good bones." (unspecified if ongoing), notes: has arthritic knees not she does not have good bones. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunization, reaction(s): "Felt very tired the next day"; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 immunization, reaction(s): "Felt very tired the next day"; Bnt162b2 (DOSE 3, SINGLE), for COVID-19 immunization, reaction(s): "Felt very tired the next day". The following information was reported: WRONG PRODUCT ADMINISTERED (non-serious), outcome "unknown", described as "Wrong vaccine administered"; FATIGUE (non-serious), outcome "unknown", described as "Felt very tired the next day".  Additional Information: The patient reported that she had received 4 shots of COVID 19 vaccines at the moment. She referred to the Bivalent gray cap vaccine as her potential third booster. She asked whether the Bivalent vaccine have some sort of extra adjunct material to make it stronger or why it was called bivalent. She also asked if there was something different in this new vaccine compared to the first three doses that she received. She was already in her appointment to receive a dose of the new Bivalent gray cap vaccine, but when she read the vaccine was not FDA approved, and the term "Bivalent", she decided not to receive the dose as she had arthritic knees not she does not have good bones. She asked if she could be irritated by receiving the 4th dose with the bivalent. She felt very tired the next day with her previous doses and asked, what was going on with the fatigue. She asked if she could be fatigue with the new bivalent. She mentioned that it was concerning, but that probably apart from being more tired that she has been with the previous vaccination, she suspected she would not suffer from anything unusual, and that she would make an appointment to receive the vaccine. She got information from some institution that this new bivalent vaccine was only tested in 8 mice and no clinical trials were conducted. She asked if this was true and what was mRNA. She asked about the ingredients of the Bivalent vaccine and for the function of the polyethylene glycol how long does it take for the body to get rid of the polyethylene glycoll contained in the vaccines.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201253451 same patient/ drug/ event, different dose number;